Home » Topics » BioWorld Science

BioWorld Science
RSS

Celgene presents new cereblon-binding PROTACs

Jan. 17, 2022

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

Machine learning approach speeds resistance identification

Jan. 17, 2022

Novel ER modulator daidzein analogues confer antitumoral effect in prostate cancer

Jan. 17, 2022

Study brings clarity on how MS starts, although not yet why

Jan. 14, 2022

[225Ac]OTSA-101 confers complete remission in preclinical model of synovial sarcoma

Jan. 14, 2022

HGF mimetic CM-1021 stimulates liver growth in mice

Jan. 14, 2022

Researchers develop a novel murine model of Cockayne syndrome

Jan. 14, 2022

Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...